Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: A systematic review and meta-analysis

International Journal of Cancer

Volumn 124, Issue 3, 2009, Pages 690-697

  Lehman, Elizabeth M ^a   Wilson, Mark L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Developing countries; Infectious diseases; Liver cancer; Pooled analysis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HEPATITIS B ANTIBODY;

ARTICLE; EGYPT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; ADULT; BLOOD; CHILD; LIVER TUMOR; META ANALYSIS; REVIEW; VIROLOGY;

ADULT; CARCINOMA, HEPATOCELLULAR; CHILD; EGYPT; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER NEOPLASMS; PREVALENCE;

EID: 58149311491     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23937     Document Type: Article

References (66)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. IARC. Monographs on the evaluation of carcinogenic risks to humans. vol.59. Lyon: International Agency for Research on Cancer, 1994.
3. WHO. Hepatitis B vaccines. Wkly Epidemiol Rec 2004;79:263.
4. WHO and the Viral Hepatitis Prevention Board. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium. J Viral Hepat 1999;6:35-47.
5. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000;14:703-9.
6. El-Zayadi AR, Badran HM, Barakat EM, Attia Mel-D, Shawky S, Mohamed MK, Selim O, Saeid A. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol 2005;11: 5193-8.
7. Hassan MM, Zaghloul AS, El-Serag HB, Soliman O, Patt YZ, Chap-pell CL, Beasley RP, Hwang LY. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol 2001;33:123-6.
8. Strickland GT, Elhefni H, Salman T, Waked I, Abdel-Hamid M, Mikhail NN, Esmat G, Fix A. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 2002;67:436-42.
9. Freedman LS, Edwards BK, Ries LAG, Young JL, eds. Cancer incidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the middle east cancer consortium (MECC) compared with US SEER. National Cancer Institute. Bethesda, MD: NIH Pub. No. 06-5873, 2006.
10. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
11. Khella AK, Faris L, Helmy S, Yosif A, Esmail S. Hepatocellular carcinoma; characteristics and possible etiologies in a group of Egyptian patients. J Egypt Public Health Assoc 1992;67:741-52.
12. Yates SC, Hafez M, Beld M, Lukashov VV, Hassan Z, Carboni G, Khaled H, McMorrow M, Attia M, Goudsmit J. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with HCV RNA level. Am J Trop Med Hyg 1999;60:714-20.
13. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastointestin Liver Dis 2007;16:403-6.
14. Toukan AU. Hepatitis B in the Middle East: aspects of epidemiology and liver disease after infection. Gut 1996;38 (Suppl 2):S2-S4.
15. Halim AB, Garry RF, Dash S, Gerber MA. Effect of schistosomiasis and hepatitis on liver disease. Am J Trop Med Hyg 1999;60:915-20.
16. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887-91.
17. El-Zayadi AR. Curse of schistosomiasis on Egyptian liver. World J Gastroenterol 2004;10:1079-81.
18. Strickland GT. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 2006;43:915-22.
19. Sharara AI, Ramia S, Ramlawi F, Fares JE, Klayme S, Naman R. Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other middle Eastern countries. Epidemiol Infect 2007;135:427-32.
20. Arafa N, El Hoseiny M, Rekacewicz C, Bakr I, El-Kafrawy S, El Daly M, Aoun S, Marzouk D, Mohamed MK, Fontanet A. Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol 2005;43:418-24.
21. El Gaafary MM, Rekacewicz C, Abdel-Rahman AG, Allam MF, El Hosseiny M, Hamid MA, Colombani F, Sultan Y, El-Aidy S, Fontanet A, Mohamed MK. Surveillance of acute hepatitis C in Cairo, Egypt. J Med Virol 2005;76:520-5.
22. WHO. Hepatitis B surface antigen assays: operational characteristics (Phase I). Report 1. Geneva: World Health Organisation, 2001.
23. WHO. Hepatitis C assays: operational characteristics (Phase II). Report 2. Geneva: World Health Organisation, 2001.
24. Booth JC, O'Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C. Gut 2001;49 (Suppl 1):I1-I21.
25. Central Agency for Public Mobilization and Statistics. Statistical year book. Cairo, Egypt: CAPMAS, 2005.
26. Reijnders J, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008;23:183-9.
27. Attia MAM, Zekri ARN, Goudsmit J, Boom R, Khaled HM, Mansour MT, de Wolf F, el-Din HM, Sol CJ. Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors. J Clin Microbiol 1996;34:2665-9.
28. Sherif MM, Abou-Aita BAS, Abou-Elew MH, El-Kafrawi A. Hepatitis B virus infection in upper and lower Egypt. J Med Virol 1985; 15:129-35.
29. Gumie MAB, Tawfik Ali TM. A sero survey for hepatitis B, syphilis and human immuno deficiency virus antibodies among blood donors and recipients. New Egyp J Med 1990;4:973-6.
30. El Sherbini A, Mohsen SA, Seleem Z, Ghany AA, Moneib A, Abaza AH. Hepatitis B virus among schoolchildren in an endemic area in Egypt over a decade: impact of hepatitis B vaccine. Am J Infect Control 2006;34:600-2.
31. El Hawey AM, Abdel Hafez MA, Ibrahim MS, Ahmed GN, Hebisha MA. Hepatitis B virus markers in schistosomiasis patients in a village in Menoufia governorate. Egypt, and their response to Praziquantel. New Egypt J Med 1993;8:1206-10.
32. Arthur RR, Hassan NF, Abdallah MY, El-Sharkawy MS, Saad MD, Hackbart BG, Imam IZ. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt Trans R Soc Trop Med Hyg 1997;91:271-4.
33. Mabrouk MA, Abdel-Rahim AY, Zakaria S, El-Garem A. The low frequency of hepatitis B virus infection in schistosomal and non-schistosomal Egyptian army recruits. New Egypt J Med 1994;10:2263-7.
34. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edel-man R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 1993;49:440-7.
35. Darwish MA, Faris R, Darwish N, Shouman A, Gadallah M, El-Shar-kawy MS, Edelman R, Grumbach K, Rao MR, Clemens JD. Hepatitis C and cirrhotic liver disease in the Nile delta of Egypt: a community-based study. Am J Trop Med Hyg 2001;64:147-53.
36. Reda AA, Arafa MA, Youssry AA, Wandan EH, Ab de Ati M, Dae-bees H. Epidemiologic evaluation of the immunity against hepatitis B in Alexandria. Egypt Eur J Epidemiol 2003;18:1007-11.
37. El SherbiniA, Mohsen SA, HasanW, Mostafa S, El Gohary K, Moneib A, Abaza AH. The peak impact of an Egyptian outbreak of hepatitis C virus: has it passed or not yet occurred? Liver Int 2007;27:876-7.
38. Fathalla SES. Hepatitis C infection among Egyptian blood donors in the eastern Saudi Arabia with/without past history of schistosomiasis. Arch STD HIV Res 1994;8:71-5.
39. Kumar RM, Frossad PM, Hughes PF. Seroprevalence and mother-to-infant transmission of hepatitis C in asymptomatic Egyptian women. Eur J Obstet Gynecol Reprod Biol 1997;75:177-82.
40. Kassem AS, El-Nawawy AA, Massoud MN, Abou El-Nazar SY, Sobhi EM. Prevalence of hepatitis C virus (HCV) infection and its vertical transmission in Egyptian pregnant women and their newborns. J Trop Pediatr 2000;46:231-3.
41. Mohamed MK, Magder LS, Abdel-Hamid M, El-Daly M, Mikhail NN, Abdel-Aziz F, Medhat A, Thiers V, Strickland GT. Transmission of hepatitis C virus between parents and children. Am J Trop Med Hyg 2006;75:16-20.
42. Stoszek SK, Abdel-Hamid M, Narooz S, El Daly M, Saleh DA, Mikhail N, Kassem E, Hawash Y, El Kafrawy S, Said A, El Batanony M, Shebl FM, et al. Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women. Trans R Soc Trop Med Hyg 2006;100:102-7.
43. Abdel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, Thomas D, Fix AD, Strickland GT, Anwar W, Sallam I. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000;32:111-5.
44. Nafeh MA, Medhat A, Shehata M, Mikhail NNH, Swifee Y, Abdel-Hamid M, Watts S, Fix AD, Strickland GT, Anwar W, Sallam I. Hepatitis C in a community in upper Egypt: I. Cross-sectional survey. Am J Trop Med Hyg 2000;63:236-41.
45. Tanaka Y, Agha S, Saudy N, Kurbanov F, Orito E, Kato T, Abo-Zeid M, Khalaf M, Miyakawa Y, Mizokami M. Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol 2004;58:191-5.
46. Rizk MAH, Osman MI, Gaafar TM, Elawady SAA, Abdel-Hameed O. Hepatitis C virus infection among Egyptian pregnant women and its mother to infant transmission: a prospective study. New Egypt J Med 2002;27:162-72.
47. Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M, El-Kafrawy S, Esmat G, Hamid MA, Mohamed MK, Fontanet A. Higher clearance of hepatitis C virus infection in females compared with males. Gut 2006;55:1183-7.
48. Mohamed MK, Bakr I, El-Hoseiny M, Arafa N, Hassan A, Ismail S, Anwar M, Attala M, Rekacewicz C, Zalata K, Abdel-Hamid M, Esmat G, et al. HCV-related morbidity in a rural community of Egypt. J Med Virol 2006;78:1185-9.
49. Raouf AA, Hosney M, Omer A, El Gammal T, El Sebai H, Zayd IS, Abdel-Sattar L. Hepatitis C virus (HCV) in pregnancy: prevalence and risk factors for infection. Al. Azhar Med J 2004;33:235-48.
50. El-Sadawy M, Ragab H, El-Toukhy H, El-Mor AEL, Mangoud AM, Eissa MH, Afefy AF, el-Shorbagy E, Ibrahem IA, Mahrous S, Abdel-Monem A, Sabee EI, et al. Hepatitis C virus infection at Sharkia gov-ernorate. Egypt: seroprevalence and associated risk factors. J Egypt Soc Parasitol 2004;34:367-84.
51. El-Raziky MS, El-Hawary M, Esmat G, Abouzied AM, El-Koofy N, Mohsen N, Mansour S, Shaheen A, Abdel Hamid M, El-Karaksy H. Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children. World J Gastroenterol 2007;13:1828-32.
52. Ahmed L, El-Rooby AS, Rarrag A, Salama Z. Prevalence of hepatitis B virus in patients suffering from primary hepatocellular carcinoma. J Egypt Med Assoc 1986;69:363-71.
53. El-Soudani S. Study on the role of schistosomiasis and hepatitis in the development of hepatocellular carcinoma. New Egypt J Med 1993; 8:1604-7.
54. El-Sherif MZ, El-Kannishy MH, Ali AA, Ramadan F, Amra HA. Primary hepatocellular carcinoma and aflatoxicosis. New Egypt J Med 1993;8:1633-40.
55. Abdel-Wahab MF, Zakaria S, El Kady N, Omar A, Zakaria E, Milad M. Important risk factors related to hepatocellular carcinoma in Egypt. New Egypt J Med 1994;10:2276-81.
56. Abdel-Wahab M, El-Ghawalby N, Mostafa M, Sultan A, El-Sadany M, Fathy O, Salah T, Ezzat F. Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center. Hepatogas-troenterology 2007;54:157-62.
57. Angelico M, Renganathan E, Gandin C, Fathy M, Profili MC, Refai W, De Santis A, Nagi A, Amin G, Capocaccia L, Callea F, Rapicetta M, et al. Chronic liver disease in the Alexandria governorate. Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol 1997;26:236-43.
58. Mabrouk GM. Prevalence of hepatitis C infection and schistosomiasis in Egyptian patients with hepatocellular carcinoma. Dis Markers 1997;13:177-82.
59. El-Zayadi AR, Abaza H, Shawky S, Mohamed MK, Selim OE, Badran HM. Prevalence and epidemiological features of hepatocellular carcinoma in Egypt-A single center experience. Hepatol Res 2001;19:170-9.
60. El-Kafrawy SA, Abdel-Hamid M, El-Daly M, Nada O, Ismail A, Ezzat S, Abdel-Latif S, Abdel-Hamid A, Shields PG, Loffredo C. p53 mutations in hepatocellular carcinoma patients in Egypt. Int J Hyg Environ Health 2005;208:263-70.
61. Ezzat S, Abdel-Hamid M, Eissa SA, Mokhtar N, Labib NA, El-Ghorory L, Mikhail NN, Abdel-Hamid A, Hifnawy T, Strickland GT, Loffredo CA. Associations of pesticides. HCV, HBV, and hepatocellular carcinoma in Egypt. Int J Hyg Environ Health 2005;208:329-39.
62. Lohiniva AL, Talaat M, Bodenschatz C, Kandeel A, El-Adawy M, Earhart K, Mahoney FJ. Therapeutic injections in the context of Egyptian culture. Promot Educ 2005;12:13-8.
63. Deuffic-Burban S, Mohamed MK, Larouze B, Carrat F, Valleron AJ. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol 2006;44:455-61.
64. Lehman EM, Soliman AS, Ismail K, Hablas A, Seifeldin IA, Ramadan M, El-Hamzawy H, Shoushtari CS, Wilson ML. Patterns of hepatocellular carcinoma incidence in Egypt from a population-based cancer registry. Hepatol Res 2008;38:465-73.
65. John TJ, Abraham P. Hepatitis B in India: a review of disease epidemiology. Indian Pediatr 2001;38:1318-22.
66. Batham A, Narula D, Toteja T, Sreenivas V, Puliyel JM. Systematic review and meta analysis of prevalence of hepatitis B in India. Indian Pediatr 2007;44:663-75.